Pharmasum Therapeutics
PrivateLast Round
Crowdfunding
Jun 28, 2023
Total Funding Raised
$3.27M
Company Overview
Pharmasum Therapeutics is a biotechnology company focused on the discovery and development of novel human medicines for the treatment of neurological, autoimmune, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmasum Therapeutics Comparables
Compare Pharmasum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perha Pharmaceuticals | 87% | |
| T3D Therapeutics, Inc. | 77% | |
| AgeneBio, Inc. | 72% | |
Pharmasum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 28, 2023 | ||||
| Grant | Feb 5, 2015 |
Pharmasum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovasjon Norge | Grant |
| Folkeinvest | Crowdfunding |
Pharmasum Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pharmasum Therapeutics's valuation, stock price, and market status.